Domov › Crohnova bolezen › Massachusetts
Klinične študije za Crohnova bolezen v Massachusetts
27 študij za Crohnova bolezen išče udeležence na lokacijah v Massachusetts.
Mesta v Massachusetts
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Massachusetts General Hospital, Boston
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07033208A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
Vključevanje udeležencevFaza 4
Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Boston Childrens Hospital, Boston
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Lucida Clinical Trials /ID# 266548, New Bedford
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, New Bedford
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tufts Medical Center-Site Number: 8400126, Boston
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
Vključevanje udeležencevFaza 3
Starost 2–19 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Boston Children's Hospital, Boston
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05509777Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Vključevanje udeležencevFaza 1/2
Starost 12–80 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT04263831Cranberry and Gut Health in Crohn's Disease
- UMASS medical center, Worcester
Vključevanje udeležencevZgodnja faza 1
Starost 18–65 · Vsi spoli · Posodobljeno 20. jul. 2026 · NCT07170462Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Boston Children's Hospital /ID# 262191, Boston
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT06332534Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Boston Children's Hospital, Boston
Vključevanje udeležencevFaza 4
Starost 6–17 · Vsi spoli · Posodobljeno 27. maj 2026 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Boston Children's Hospital, Boston
Vključevanje udeležencevFaza 3
Starost 2–17 · Vsi spoli · Posodobljeno 5. maj 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, LLC, New Bedford
- University of Massachusetts, Worcester, Worcester
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400022, Boston
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06958536Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
Vključevanje udeležencevOpazovalna študija
Starost 18–99 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT06252493Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Massachusetts General Hospital, Boston
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 14 in več · Vsi spoli · Posodobljeno 30. jan. 2026 · NCT05332639A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Massachusetts General Hospital, Boston
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–75 · Vsi spoli · Posodobljeno 16. dec. 2025 · NCT07219537Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- Boston Children's Hospital, Boston
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 13–20 · Vsi spoli · Posodobljeno 30. okt. 2025 · NCT04508088High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
Vključevanje udeležencevOpazovalna študija
Starost 5–25 · Vsi spoli · Posodobljeno 3. mar. 2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 14 in več · Vsi spoli · Posodobljeno 20. dec. 2024 · NCT06655415Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.